Blood tests are remarkably accurate at the analytical stage, where modern instruments measure chemical concentrations, but the full process from arm to report has enough moving parts that errors creep in more often than most people assume. Studies tracking laboratory mistakes across the entire testing chain find that somewhere between roughly 0.1% and 3% of all specimens involve a detectable error at some point, with the vast majority occurring before or after the sample reaches the analyzer. That gap between “the machine is precise” and “the result you receive is correct” is where the interesting problems live, and understanding it can save you from unnecessary worry or, in rarer cases, a missed diagnosis.
Most Mistakes Have Nothing to Do With the Machine
If you picture a blood test error as a glitch in the laboratory instrument, you are picturing the least common scenario. Decades of quality data show that errors cluster overwhelmingly in the pre-analytical phase, meaning everything that happens before the sample is actually analyzed: patient preparation, blood draw technique, tube labeling, transport, and storage. One review found that pre-analytical factors account for roughly 46% to 68% of total laboratory errors, while a further 18% to 47% occur in the post-analytical phase, which includes data entry, result reporting, and interpretation.1PubMed. Errors in clinical laboratories or errors in laboratory medicine? A separate study at a teaching hospital in Tehran broke down the numbers slightly differently, finding about 65% pre-analytical, 23% analytical, and 12% post-analytical.2PubMed Central. Types and Frequency of Errors during Different Phases of Testing At a Clinical Medical Laboratory of a Teaching Hospital in Tehran, Iran
Either way, the pattern is consistent: the actual measurement step, where highly calibrated instruments do their work, is the least error-prone part. The human steps on either side of the machine are where things go sideways. This is good news in one sense, because it means the chemistry and physics of modern analyzers are solid. It is less reassuring in another sense, because it means the weakest links involve people, and people are hard to standardize.
What Goes Wrong During the Blood Draw
The single most common pre-analytical problem is hemolysis, which is what happens when red blood cells rupture and spill their contents into the liquid portion of the sample. A hemolyzed sample can throw off readings for potassium, liver enzymes, and several other analytes because those substances naturally exist at higher concentrations inside red blood cells than in plasma.3PubMed Central. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories
What causes it? A lot of mundane things. Drawing blood through an intravenous catheter instead of a standard needle, using veins that are harder to access (like the back of the hand rather than the inner elbow), keeping the tourniquet on too long, underfilling the collection tube, or shaking the tube too vigorously during transport can all burst cells.4PubMed. Causes, consequences and management of sample hemolysis in the clinical laboratory Emergency departments have particularly high hemolysis rates, likely because blood draws happen faster, on sicker patients, and sometimes through existing IV lines rather than dedicated venipuncture.5PubMed. Key factors influencing the incidence of hemolysis: A critical appraisal of current evidence Samples drawn by professional phlebotomists (people whose entire job is drawing blood) tend to hemolyze less than those drawn by nurses or doctors juggling other tasks.
A hemolyzed sample does not always produce a wrong result, though. Labs flag visibly hemolyzed specimens and can reject them or note the interference. The danger is when hemolysis is mild enough to escape visual detection or when results are released without the flag being noticed by the ordering clinician.
How Labs Spot Problem Samples Before Reporting Results
Modern clinical chemistry analyzers do not simply measure your analytes and spit out numbers. They also run what are called serum indices: automated spectrophotometric checks that look for hemolysis, icterus (excess bilirubin, which turns the sample yellow), and lipemia (excess fat particles, which turns it milky).6PubMed. Serum indices: managing assay interference These are reported as semi-quantitative indices, often labeled H, I, and L, and they tell the lab whether the sample’s condition could skew specific tests.7Lab Med Online. Proposal of Modified HIL-indices for Determining Hemolysis, Icterus and Lipemia Interference on the Beckman Coulter AU5800 Automated Platform
Another safety net is the delta check, an electronic tool that compares your current result with your previous result for the same test. If the difference exceeds a preset threshold, the system flags the result for human review before it reaches your doctor. Delta checks were originally designed to catch sample mix-ups, where your tube gets someone else’s label, but they now serve as a broader error-detection tool across the testing process.8PubMed. Delta checks
These safeguards are why most errors do not reach you as a final report. The system catches and corrects many of them internally. But “many” is not “all,” and some classes of error, particularly those involving patient identification, can slip through because neither the machine nor the delta check knows you are not the person on the label.
Wrong Patient, Wrong Tube
Patient misidentification errors are rare in absolute terms but potentially catastrophic when they happen. The consequences range from someone else’s blood type being assigned to you (dangerous if a transfusion follows) to your abnormal result being attributed to someone who does not need treatment, while you walk away without follow-up. One review estimated that misidentification of general laboratory specimens occurs at a rate around 1%, and while most are caught before causing harm, the potential for misdiagnosis and inappropriate therapy makes these errors especially high-stakes.9CLINICAL CHEMISTRY AND LABORATORY MEDICINE. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
This is the kind of error that no amount of instrument calibration can prevent. It depends on whether the person drawing your blood verified your identity, labeled the tube at the bedside, and did not mix your sample up with the one from the patient next door. Barcoded wristbands and electronic labeling systems have driven these rates down in hospitals that adopt them, but the problem persists wherever manual labeling is still standard.
Your Body Changes the Numbers, Not Just the Lab
Even when the blood draw is flawless and the analyzer is perfectly calibrated, your results can shift based on the time of day, what you ate, how much water you drank, and whether you exercised recently. These are not errors in the usual sense, but they produce results that look abnormal when compared to a reference range established under standardized conditions.
A study tracking healthy young men through a full 24-hour cycle found that hemoglobin, red blood cell counts, iron, and transferrin saturation all fell gradually through the day, reaching their lowest point around midnight, while white blood cell counts did the opposite, rising through the day and peaking at midnight.10PubMed. Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations Iron showed some of the largest swings relative to its reference interval. If you have your blood drawn early in the morning versus late in the afternoon, your iron level alone could look meaningfully different even though nothing has changed about your health.
Hydration matters too. A study of dehydration protocols found that losing around 3% to 4% of body mass through fluid loss raised hemoglobin concentrations enough that, in some individuals, the change triggered alerts designed to catch doping in athletes. Diuretic-induced dehydration (which mimics what happens during a stomach illness) was the bigger culprit; sweating alone did not produce the same magnitude of shift.11PubMed. Potential for dehydration to impact the athlete biological passport For an everyday patient, this means showing up for a fasting blood test after a night of poor hydration could nudge certain values outside the expected range without reflecting any underlying disease.
Reference Ranges Guarantee Some “Abnormal” Results in Healthy People
This is the part that trips up a lot of people. A blood test’s reference range is typically defined as the middle 95% of values found in a healthy population. That means, by design, 5% of perfectly healthy individuals will fall outside the range for any single test. Run a panel of 20 tests on a completely healthy person, and there is roughly a 64% chance that at least one result will come back flagged as abnormal.12Postgraduate Medical Journal. The normal range: it is not normal and it is not a range That is not an error in the lab; it is a statistical inevitability built into how reference ranges work.
Doctors are trained to interpret results in context, not to react to a single flagged value in isolation. But patients who receive their lab reports through an online portal often see the red “H” or “L” flags and assume something is wrong. If you have ever had one slightly out-of-range result in a panel where everything else looked fine, the statistical explanation above is almost certainly the reason.
Screening Tests and the False-Positive Trap
The word “wrong” gets used loosely. When a blood test produces a result that does not match reality, it could be because of a lab error, because your body was in an unusual state, or because the test itself has inherent limits in sensitivity and specificity. Screening tests designed to detect disease in seemingly healthy people are especially prone to false positives, because they are tuned to be sensitive (catch as many cases as possible), which inevitably drags along some people who are healthy.
A cohort study looking at PSA testing for prostate cancer illustrates this starkly. Among men with a positive PSA result, the positive predictive value was only about 13%, meaning that roughly 87% of men flagged by the test did not have prostate cancer. The false-positive rate was nearly 47%.13PubMed Central. Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data On the flip side, the negative predictive value was above 99%, meaning that a negative PSA result was extremely reliable for ruling cancer out. This is a common pattern in screening: the test is better at telling you that you are probably fine than at confirming you are definitely sick.
False positives can cause real harm beyond the initial anxiety. They often trigger additional imaging, biopsies, repeat blood work, and specialist referrals, each carrying its own costs, risks, and time. A primary-care study found that roughly a third of all lab panels led to downstream diagnostic or treatment actions, including additional tests, referrals, or new medications.14BMJ Open. Downstream activities after laboratory testing in primary care: an exploratory outcome of the ELMO cluster randomised trial When the original lab result was a false positive, all of those downstream activities were unnecessary.
Substances That Interfere With Blood Tests
Some things you put in your body can directly distort test results, and many people have no idea. Biotin, a B vitamin found in supplements, multivitamins, and hair-and-nail products, is one of the best-documented offenders. It can interfere with immunoassay-based tests, affecting results for thyroid hormones, certain cancer markers, and cardiac biomarkers. A study of over 1,900 patients found that about 42% were taking multivitamins and nearly 8% were taking biotin supplements, yet biotin use was recorded in the medical chart for only a tiny fraction of those with measurably elevated levels.15American Thyroid Association. Biotin supplement use is common and can lead to the false measurement of thyroid hormone in commonly used assays If your doctor does not know you are taking biotin, they have no reason to suspect the result might be artifactual.
Medications can produce false positives as well. A case report documented a child with diphenhydramine (Benadryl) overdose whose urine drug screen came back positive for tricyclic antidepressants, a class of drug the child had never taken. The structural similarity between diphenhydramine and tricyclic antidepressants caused cross-reactivity on the immunoassay.16PubMed Central. Diphenhydramine Intoxication With Blood Extended Half-Life and a False Positive Result for Tricyclic Antidepressants This kind of cross-reactivity is not a fluke; it affects many rapid drug screening panels, where the initial test is designed for speed rather than precision, and a confirmatory test using a different method is needed to determine whether the positive is real.
The practical lesson here: always tell whoever is ordering your blood work about every supplement, vitamin, and over-the-counter medication you are taking. That includes seemingly harmless things like biotin, melatonin, and antihistamines. If a result looks unexpected, the first question your doctor should ask is whether something you ingested might have interfered.
Fingerstick and Point-of-Care Tests
Increasingly, blood tests happen outside the traditional venous draw and central laboratory. Point-of-care devices use fingerstick capillary blood to deliver results in minutes, and they are used everywhere from pharmacies to remote clinics to home testing kits. The convenience is real, but so are the accuracy trade-offs.
A study comparing capillary and venous blood for 34 routine chemistry analytes found that most showed excellent comparability, with 30 out of 33 tests meeting allowable error criteria.17PubMed. Comparison of capillary finger stick and venous blood sampling for 34 routine chemistry analytes: potential for in hospital and remote blood sampling But there are notable exceptions. Glucose did not meet the stricter federal accuracy criteria when measured by fingerstick versus venous draw, which matters because glucose is one of the most commonly tested analytes in point-of-care settings.
Hemoglobin measurements from fingersticks show meaningful variability. In a study of blood donors, capillary hemoglobin readings ran slightly higher than venous values, which led to about 6% of donors passing the screening by fingerstick who would have been deferred if tested by venous blood. Repeated fingerstick measurements on the same person showed absolute differences averaging about 0.76 g/dL between paired samples, which is a substantial swing for a test with clinical thresholds that matter.18PubMed Central. Capillary versus venous haemoglobin determination in the assessment of healthy blood donors
Proteomic research has taken a broader look at the correlation between capillary and venous samples. About two-thirds of proteins tested showed strong correlation between the two collection methods, but one in five proteins showed weak or very weak correlation, and protein expression was consistently higher in capillary samples for those less-correlated analytes.19PubMed Central. Comparing Venous vs. Capillary Blood Collection Methods for Proteomic Measurement in Peripheral Blood For routine chemistry, fingerstick tests are adequate for most purposes. For anything where borderline values drive clinical decisions, a venous draw from a central lab is still the gold standard.
Variation Between Laboratories
You might assume that a blood test is a blood test, and that the same sample sent to two different labs would produce the same number. It usually will for common analytes like sodium, glucose, or hemoglobin. But for more complex tests, especially coagulation studies, immunoassays, and specialized panels, the lab performing the test can influence the result.
A nationwide evaluation of coagulation testing found that even when laboratories used identical analytical platforms, the variance attributable to technician technique and laboratory-specific procedures was substantial. For several clotting factors, the agreement between labs was disappointingly low.20PubMed Central. Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study This is one reason why clinicians are advised to use the same laboratory for serial measurements when tracking a value over time, rather than switching between providers.
Proficiency testing programs, where labs periodically analyze standardized samples and compare their results against known values and against each other, are the main tool for keeping this variation in check.21PubMed. The role of proficiency testing in achieving standardization and harmonization between laboratories Accredited labs participate in these programs as a condition of their license. But participation does not eliminate inter-laboratory variation; it limits it.
Direct-to-Consumer Lab Tests
The explosion of companies offering blood tests you can order yourself, without a doctor’s prescription, raises a distinct set of accuracy concerns. The analytical instruments used by the labs processing these tests may be the same ones used in clinical settings, but the regulatory environment is different. A review of the direct-to-consumer testing landscape noted that while medical laboratory testing is tightly regulated, the direct-to-consumer segment operates through regulatory gaps: the same quality mandates that apply in healthcare settings are not always enforced for consumer-ordered tests.22PubMed Central. Direct to Consumer Laboratory Testing (DTCT) – Opportunities and Concerns
A study of US companies offering direct-to-consumer lab tests found that some companies disclosed potential risks including lack of accuracy and the need for healthcare professional follow-up, though disclosure practices varied widely.23JAMA Internal Medicine. Policies of US Companies Offering Direct-to-Consumer Laboratory Tests The bigger problem may not be the test itself but the interpretation. Without a clinician who knows your medical history, medications, and the clinical context, even an accurate number can be misread. A slightly elevated liver enzyme in someone who ran a marathon yesterday means something very different from the same number in someone who has been sedentary.
When a “Wrong” Result Is Actually the Test Working as Designed
It helps to separate genuine errors (the lab got the number wrong) from inherent test limitations (the test gave a correct number that does not mean what you think it means). A PSA level of 5 ng/mL in a man with an enlarged prostate is not wrong; it is accurately reflecting the PSA in his blood. The test just cannot tell you whether that PSA came from cancer or from a benign condition. Similarly, a mildly elevated fasting glucose in someone who unknowingly had a sip of juice is not a lab error. The glucose measurement is correct; it just does not reflect the patient’s true fasting state.
Understanding this distinction matters because the response is different. For a genuine lab error, the fix is to repeat the test. For a test working within its known limitations, the fix might be a different test, additional context, or clinical judgment about whether the result matches the rest of the picture. Your doctor’s job is to figure out which category applies, and asking questions like “Could anything I ate, drank, or took as a supplement have affected this?” or “Should we repeat this before acting on it?” is always reasonable when a result surprises you.
How to Reduce Your Own Risk of Getting a Wrong Result
You cannot control everything that happens to your blood sample after it leaves your arm, but you can influence several of the biggest error-prone steps:
- Follow fasting instructions exactly. If the test requires fasting, that typically means nothing but water for 8 to 12 hours beforehand. Even small amounts of food or sweetened drinks can shift glucose and lipid panels.
- Disclose supplements and medications. Biotin, antihistamines, herbal supplements, and many prescription drugs can interfere with specific assays. Give a complete list, not just prescription medications.
- Stay reasonably hydrated. Dehydration concentrates your blood and pushes values like hemoglobin upward. Drink water normally before your draw unless told otherwise.
- Stick with one lab for serial monitoring. If you are tracking cholesterol, thyroid function, or another value over time, using the same laboratory reduces inter-lab variation and makes trends more reliable.
- Verify your identity at the draw. It sounds obvious, but confirm your name and date of birth when the phlebotomist asks. That simple step is the primary defense against mislabeled tubes.
- Ask about timing. For tests known to fluctuate through the day, such as iron or cortisol, drawing at the same time of day for repeat measurements improves comparability.
None of these steps guarantee a perfect result, but they address the most common sources of pre-analytical error, which, as the data consistently show, is where the overwhelming majority of problems originate.